Skip to content
10-K

Annual Report

ENDOCYTE INC

0001558370-18-001164

← back to feed
Filed
Feb 27, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Feb 23, 2018 48.35M sh
Stock Repurchased FY 2017 · Dec 31, 2017 $94.63K
Stock Repurchased FY 2017 · Dec 31, 2016 $164.47K
Stock Repurchased FY 2017 · Dec 31, 2015 $57.27K
Capex FY 2017 · Dec 31, 2017 $82.46K
Capex FY 2017 · Dec 31, 2016 $713.84K
Capex FY 2017 · Dec 31, 2015 $341.62K
Operating Cash Flow FY 2017 · Dec 31, 2017 −$33.66M
Operating Cash Flow FY 2017 · Dec 31, 2016 −$34.65M
Operating Cash Flow FY 2017 · Dec 31, 2015 −$32.22M
Cash And Equivalents FY 2017 · Dec 31, 2017 $18.56M
Cash And Equivalents FY 2017 · Dec 31, 2016 $31.23M
Cash And Equivalents FY 2017 · Dec 31, 2015 $15.43M
Cash And Equivalents FY 2017 · Dec 31, 2014 $45.53M
Stockholders Equity FY 2017 · Dec 31, 2017 $95.48M
Stockholders Equity FY 2017 · Dec 31, 2016 $137.15M
Stockholders Equity FY 2017 · Dec 31, 2015 $171.35M
Stockholders Equity FY 2017 · Dec 31, 2014 $205M
Current Liabilities FY 2017 · Dec 31, 2017 $4.55M
Current Liabilities FY 2017 · Dec 31, 2016 $5.56M
Total Liabilities FY 2017 · Dec 31, 2017 $5.28M
Total Liabilities FY 2017 · Dec 31, 2016 $6.35M
Current Assets FY 2017 · Dec 31, 2017 $98.57M
Current Assets FY 2017 · Dec 31, 2016 $140.26M
Total Assets FY 2017 · Dec 31, 2017 $100.76M
Total Assets FY 2017 · Dec 31, 2016 $143.49M
Sga Expense FY 2017 · Dec 31, 2017 $3.71M
Sga Expense FY 2017 · Dec 31, 2017 $13.77M
Sga Expense FY 2017 · Sep 30, 2017 $3.01M
Sga Expense FY 2017 · Jun 30, 2017 $3.31M
Sga Expense FY 2017 · Mar 31, 2017 $3.75M
Sga Expense restated FY 2017 · Dec 31, 2016 $3.1M
Sga Expense FY 2017 · Dec 31, 2016 $17.3M
Sga Expense restated FY 2017 · Sep 30, 2016 $2.99M
Sga Expense restated FY 2017 · Jun 30, 2016 $7.39M
Sga Expense restated FY 2017 · Mar 31, 2016 $3.82M
Sga Expense FY 2017 · Dec 31, 2015 $15.73M
Rd Expense FY 2017 · Dec 31, 2017 $5.13M
Rd Expense FY 2017 · Dec 31, 2017 $25.87M
Rd Expense FY 2017 · Sep 30, 2017 $4.09M
Rd Expense FY 2017 · Jun 30, 2017 $8.66M
Rd Expense FY 2017 · Mar 31, 2017 $7.99M
Rd Expense restated FY 2017 · Dec 31, 2016 $8.19M
Rd Expense FY 2017 · Dec 31, 2016 $27.49M
Rd Expense restated FY 2017 · Sep 30, 2016 $5.99M
Rd Expense restated FY 2017 · Jun 30, 2016 $6.79M
Rd Expense restated FY 2017 · Mar 31, 2016 $6.53M
Rd Expense FY 2017 · Dec 31, 2015 $26.31M
Net Income FY 2017 · Dec 31, 2017 −$8.56M
Net Income FY 2017 · Dec 31, 2017 −$55.06M
Net Income FY 2017 · Sep 30, 2017 −$23.27M
Net Income FY 2017 · Jun 30, 2017 −$11.74M
Net Income FY 2017 · Mar 31, 2017 −$11.49M
Net Income restated FY 2017 · Dec 31, 2016 −$11.07M
Net Income FY 2017 · Dec 31, 2016 −$43.89M
Net Income restated FY 2017 · Sep 30, 2016 −$8.71M
Net Income restated FY 2017 · Jun 30, 2016 −$13.96M
Net Income restated FY 2017 · Mar 31, 2016 −$10.15M
Net Income FY 2017 · Dec 31, 2015 −$41.27M
Operating Income FY 2017 · Dec 31, 2017 −$8.87M
Operating Income FY 2017 · Dec 31, 2017 −$56.11M
Operating Income FY 2017 · Sep 30, 2017 −$23.56M
Operating Income FY 2017 · Jun 30, 2017 −$11.95M
Operating Income FY 2017 · Mar 31, 2017 −$11.73M
Operating Income restated FY 2017 · Dec 31, 2016 −$11.27M
Operating Income FY 2017 · Dec 31, 2016 −$44.72M
Operating Income restated FY 2017 · Sep 30, 2016 −$8.94M
Operating Income restated FY 2017 · Jun 30, 2016 −$14.17M
Operating Income restated FY 2017 · Mar 31, 2016 −$10.34M
Operating Income FY 2017 · Dec 31, 2015 −$41.97M
Revenue FY 2017 · Dec 31, 2017 $12K
Revenue FY 2017 · Dec 31, 2017 $70K
Revenue FY 2017 · Sep 30, 2017 $33K
Revenue FY 2017 · Jun 30, 2017 $13K
Revenue FY 2017 · Mar 31, 2017 $12K
Revenue restated FY 2017 · Dec 31, 2016 $12K
Revenue FY 2017 · Dec 31, 2016 $70K
Revenue restated FY 2017 · Sep 30, 2016 $33K
Revenue restated FY 2017 · Jun 30, 2016 $13K
Revenue restated FY 2017 · Mar 31, 2016 $12K
Revenue FY 2017 · Dec 31, 2015 $70K